PALI (Palisade Bio) Common Stock: $1.67 Mil (As of Mar. 2026)


PALI Palisade Bio Inc PALI
35 GF Score
Price $2.08
! 2 Warning Signs
View Full Analysis

What is Palisade Bio Common Stock?

Palisade Bio PALI +5.33% 35 Common Stock is $1.67 Mil as of Mar. 2026. GuruFocus rates PALI with a GF Score™ of 35/100. The stock has 2 warning signs investors should review.

Palisade Bio's quarterly common stock increased from Sep. 2025 ($0.09 Mil) to Dec. 2025 ($1.59 Mil) and increased from Dec. 2025 ($1.59 Mil) to Mar. 2026 ($1.67 Mil).

Palisade Bio's annual common stock increased from Dec. 2023 ($0.01 Mil) to Dec. 2024 ($0.03 Mil) and increased from Dec. 2024 ($0.03 Mil) to Dec. 2025 ($1.59 Mil).

Palisade Bio Common Stock Historical Data

* Premium members only.

The historical data trend for Palisade Bio's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Palisade Bio Common Stock Chart

Palisade Bio Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Common Stock
Get a 7-Day Free Trial 0.00 0.03 0.01 0.03 1.59

Palisade Bio Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.04 0.05 0.09 1.59 1.67
PALI
35GF Score
Palisade Bio Inc PALI
Common Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Palisade Bio Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of $1.67 Mil mean?
Palisade Bio (PALI) has a Common Stock of $1.67 Mil as of Mar. 2026. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Palisade Bio and its competitors.
Is Palisade Bio's Common Stock too high?
Palisade Bio's current Common Stock is $1.67 Mil. Overall, Palisade Bio has a GF Score™ of 35/100, reflecting its overall financial health beyond just this single metric.
How does Palisade Bio's Common Stock compare to IRD and GALT?
Palisade Bio's Common Stock of $1.67 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Biotechnology company?
A good Common Stock depends on the Biotechnology industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Palisade Bio and its competitors. Palisade Bio's current Common Stock is $1.67 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Palisade Bio stock overvalued right now?
Palisade Bio (PALI) has a current Common Stock of $1.67 Mil. The current Common Stock is $1.67 Mil. Palisade Bio's overall GF Score™ is 35/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Palisade Bio (PALI), the current Common Stock is $1.67 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Palisade Bio Business Description

Address 4600 South Syracuse Street, Suite 900, Denver, CO, USA, 80237
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.
35GF Score

Get the complete analysis for PALI

Common Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.08
Price